In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TherOx Inc.

www.therox.com

Latest From TherOx Inc.

Zoll Zeroes In On TherOx, Acquires SSO2 Therapy

Just months after receiving USA FDA approval for its SuperSaturated Oxygen (SSO2) Therapy for heart-attack treatment, Californian company TherOx has been acquired by Zoll Medical for an undisclosed sum.

Cardiovascular Cardiology

Global Device Approvals Snapshot: April 2-8, 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, FDA approved TherOx’s Supersaturated Oxygen System. PharmaEngine/Nanobiotix said its Hensify NBTXR3 nano-particles received the CE mark and plans to market it in 27 European countries for treating locally advanced soft tissue sarcoma.

Research & Development Approvals

FDA Approves TherOx’s SuperSaturated Oxygen Heart Attack Therapy

Clinical trials have shown that SuperSaturated Oxygen Therapy (SSO2 Therapy) reduces the size of myocardial infarcts in the regions of the heart-muscle perfused by the patient’s left anterior descending coronary artery immediately following stenting.

Approvals Research & Development

Three Devices Gain Medicare Add-Ons, Including Boston Sci's New TAVR Protector

The US Medicare agency granted inpatient new-technology add-on payments for Boston Scientific's newly acquired cerebral protection system for TAVR, Respicardia's neurostimulator for sleep apnea and Procept BioRobotics' novel resection system for benign prostatic hyperplasia. The highly selective bonus payments typically help drive adoption for the chosen new technologies.

Reimbursement Market Access
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • TherOx Inc.
  • Senior Management
  • Kevin T Larkin, Pres. & CEO
    Shelley Thunen, CFO
    Robert K Weigle, VP, Sales & Mktg.
  • Contact Info
  • TherOx Inc.
    Phone: (949) 757-1999
    17500 Cartwright Rd.
    Ste. 100
    Irvine, CA 92614-5846
    USA
UsernamePublicRestriction

Register